Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Insiders Of Aldeyra Therapeutics Retain US$852k Of Investment Selling At Higher Prices
Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)
Aldeyra Therapeutics: A Buy Rating on Strong Clinical Progress and Market Potential
Express News | Aldeyra Therapeutics Inc : Jefferies Raises Target Price to $8 From $7